The system has two single-use components: a pre-filled cannula with bone graft material and the delivery device. It’s indicated for spine and orthopedic procedures requiring a bone graft.
“ViviGen MIS brings graft delivery for minimally invasive procedures into the 21st Century,” Rony Thomas, president and CEO said in a Sept. 28 news release. “It is a quantum leap forward that combines the clinical advantages of ViviGen with a fast, consistent delivery experience that eliminates one of the lingering challenges in MIS procedures.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.